Wile E. Peyote

With the help EGA and our ethnobotanical family I wrote this resource to encourage awareness of Peyote conservation - "If you grow Peyote, are curious about cultural uses of these plants or the area of psychedelic conservation, our Peyote conservation reference guide can shed light on the ethical complexities of a relationship with this threatened species. The guide also provides species descriptions, history, pharmacology and other safety and legal issues around these plants. It features many beautiful photographs and includes contributions from Dr Liam Engel, Keeper Trout, Dr Martin Terry, Torsten Weidemann, Jonathan Carmichael and Andrew Oliver. Download the Peyote conservation reference guide here: https://gardenstates.entheogenesis.org/reference-guide-for-lophophora-conservation/ Check out more EGA resources here: https://gardenstates.entheogenesis.org/resources/" Lockdown sucks, I was so looking forward to seeing you all in December. Here's hoping it isn't too much longer. Miss you all!

Systematic literature review of the therapeutic value, benefits and risks of MDMA and psilocybin for the treatment of mental health conditions 5 August 2021 The Therapeutic Goods Administration (TGA) Scheduling Delegate (decision maker) has deferred the final decision on applications to down-schedule MDMA and psilocybin from schedule 9 (prohibited drug) to schedule 8 (controlled drug) pending a review into the therapeutic value, risks and benefits to public health outcomes for these substances. The Independent Expert Panel to undertake this review has now been established. Terms of Reference The Independent Expert Panel has been established to undertake a systematic literature review of the roles of MDMA and psilocybin for the treatment of mental health conditions. The Review will report findings on the current state of the evidence of therapeutic value, benefits and risks of MDMA and psilocybin for the treatment of mental health conditions, including the size of effect, the quality of evidence and the applicability of the evidence to real-world use in Australia, currently and into the future. The Review excludes pre-clinical trials (i.e. experimental pharmacology studies in test tube or animal models). The Panel is not a decision making or approval body, and their role is to provide a publicly available report which will be considered by the delegate and the Advisory Committee for Medicines Scheduling. Panel Members Professor Mark Connor Professor Mark Connor is a molecular pharmacologist with expertise in analgesics and psychoactive drugs, particularly cannabinoids and opioids, with extensive research experience in the USA, UK, and Australia. Currently, his work focuses on the pharmacology of synthetic cannabinoids and the molecular effects of phytocannabinoids. Professor Connor holds a Bachelor of Science (Hons) and PhD in Pharmacology. He is currently the Associate Dean, Higher Degree Research, Department of Biomedical Sciences, Macquarie University. Professor Steve Kisely Professor Steve Kisely is a psychiatrist and public health physician with health services research experience in the UK, Australia, and Canada. He obtained fellowship of the relevant Colleges in the UK, Australasia and Canada, as well as of the Australasian Chapter of Addiction Medicine. He is also an accredited member of the faculties of adult psychiatry, addiction (FAP) and consultation psychiatry (FCLP) of the Royal Australian & New Zealand College of Psychiatrists. Professor Kisely holds a Doctor of Medicine (Research Doctor of Philosophy and Doctor of Medicine. Professor Kisely is currently Professor of Psychiatry, School of Medicine, The University of Queensland. Professor Andrew Somogyi Professor Andrew Somogyi Professor Somogyi is Professor in Clinical and Experimental Pharmacology. He is a practicing pharmacist and has a research program centred on elucidating the mechanisms and factors contributing to altered human drug response in pain therapeutics, infectious diseases, depression, and transplantation through pharmacokinetic, metabolism, pharmacodynamic and pharmacogenomic studies. He is a member of the Editorial Advisory Committee and Company Director of the Australian Medicines Handbook. Professor Somogyi holds a Certificate of Pharmacy, Diploma of Hospital Pharmacy, Master of Science, and a PhD (Clinical Pharmacology). Professor Somogyi is currently a Professor of Pharmacology, Adelaide Medical School, Faculty of Health and Medical Sciences, The University of Adelaide. Timing The Panel's Report will be published on the TGA website on 30 September 2021 ahead of consideration by the Advisory Committee on Medicines Scheduling. Contact details For enquiries regarding the Review or to contact the Panel please email [email protected] https://www.tga.gov.au/independent-expert-panel-mdma-and-psilocybin

It's all good, I had a nice vape in the park and some rude people stole our gazebo anyway

Lol I just arrived, rough

Takes me between 90min to 2hr to get there, so if we were aiming for 1pm lemme know...

We still on?

Awesome! Didn't realise these would be online so quickly. Would I have still got up at 5am on my weekend to watch this series if I had anticipated this? Yes, yes I would. I recommend the first two two talks and the final loungeroom session in particular. More of these and the EGA Microdose live streams and I can do away with TV altogether! Nice work KT, Ann and everyone else involved. Thank you all very much.

If you're convinced the current COVID-19 vaccination options aren't good for your health and you don't trust mainstream media or government communications as a source of information on the issue, try speaking to a health practitioner or a scientist, or try reading relevant health and science publications. If you don't trust these sources, I would ask you to look critically at the sources you do trust. People on this forum begrudge, disrespect and badger anti-vaxxers because not only is science and health expertise strongly represented amongst forum members, most likely view anti-vaxxers as a threat to the health of themselves, their friends and family, and the human population. This is less like drug use, which poses a risk primarily to your own health, and more like driving a car, which poses a risk to the health of others, too.

I don't think access is a part of MMA's plan for psychedelic reform either...

That's spooge, I'm sure they'll be at EGA too ;)

I'm sure all of those fellas are gonna be there, they're EGA OGs! What we really want is someone to do a cultivation workshop, I think. I have seen Chris Johns distributing courtii plants and his own cultivated courtii seed, which is pretty cool. Haven't seen much else from him though, anyone rekon he'd be good?

Damn that is way more expensive than Garden States I'm sure the content won't be anywhere near as good either.

I recommend using the forum search engine and messaging people privately, this is a bit of a sketchy topic. Search terms like 'speciosa' are likely more handy than the K word. For this reason you might also have more luck if you edit that word out of the thread title and your post. If you don't find anyone it does seem like XXX often stocks it under the counter, but you might need to find someone on good terms with the vendor to ask. I've heard their XXX store only sells small quantities for people looking for OST, but I've also seen them selling huge bags of the stuff at a festival in XXX quite recently. Worth keeping in mind that as well as being illegal this plant still works on the opioid receptors, and withdrawal, dependence and tolerance are still real risks for everyday consumers. Could be a shitty situation if you ran out of supply, but if someone is on opioids anyway I can definitely see the appeal.

I'm counting down already :D Roll call! Who else is gonna be there in person, or on the stream?